|
148
|
450
|
4c0cA |
Crystal structure of trypanosoma cruzi cyp51 bound to the inhibitor (r)-n-(3-(1h-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-4-(4-(2,4-difluorophenyl)piperazin-1-yl)-2-fluorobenzamide. |
|
159
|
450
|
4c27A |
Crystal structure of trypanosoma cruzi cyp51 bound to the inhibitor (r)-n-(3-(1h-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-2-fluoro-4-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)benzamide |
|
137
|
408
|
4c9nA |
Structure of camphor and hydroxycamphor bound d259n mutant of cyp101d1 |
|
128
|
447
|
4by0A |
Crystal structure of trypanosoma cruzi cyp51 bound to the inhibitor (r)-n-(3-(1h-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-3,3'- difluoro-(1,1'-biphenyl)-4-carboxamide |
|
155
|
449
|
4cohA |
Crystal structure of trypanosoma cruzi cyp51 bound to the sulfonamide derivative of the 4-aminopyridyl-based inhibitor |
|
136
|
408
|
4c9oA |
Structure of cyanide and camphor bound d259n mutant of cyp101d1 |
|
138
|
408
|
4c9kA |
Structure of camphor and hydroxycamphor bound wild type cyp101d1 |
|
139
|
408
|
4c9mA |
Structure of substrate free, glycerol bound wild type cyp101d1 |
|
142
|
393
|
4b7dA |
Pikc bound to the 10-dml analog with the 3-(n,n-dimethylamino) propanoate anchoring group |
|
137
|
396
|
4bf4A |
Pikc d50n mutant in complex with the engineered cycloalkane substrate mimic bearing a termianl n,n-dimethylamino group |
|
145
|
393
|
4aw3A |
Structure of the mixed-function p450 mycg f286v mutant in complex with mycinamicin v in p1 space group |
|
139
|
397
|
4b7sA |
Pikc d50n mutant bound to the 10-dml analog with the 3-(n,n- dimethylamino)propanoate anchoring group |
|
151
|
450
|
4bjkA |
Cyp51 of trypanosoma brucei bound to (s)-n-(3-(1h-indol-3-yl)-1-oxo-1- (pyridin-4-ylamino)propan-2-yl)-3,3'-difluoro-(1,1'-biphenyl)-4- carboxamide |
|
136
|
396
|
3zpiA |
Pikc d50n mutant in p21 space group |
|
145
|
414
|
4apyA |
Ethylene glycol-bound form of p450 cyp125a3 from mycobacterium smegmatis |
|
136
|
393
|
3zsnA |
Structure of the mixed-function p450 mycg f286a mutant in complex with mycinamicin iv |
|
143
|
393
|
3wvsA |
Crystal structure of cytochrome p450revi |
|
148
|
405
|
3wrlA |
Crystal structure of p450cam |
|
133
|
397
|
3zk5A |
Pikc d50n mutant bound to the 10-dml analog with the 3-(n,n-dimethylamino)ethanoate anchoring group |
|
172
|
453
|
3wspA |
Crystal structure of p450bm3 with n-perfluorononanoyl-l-tryptophan |
|
138
|
407
|
3wriA |
Crystal structure of p450cam |
|
137
|
391
|
3zkpA |
Structure of a mutant of p450 eryk in complex with erythromycin b. |
|
141
|
407
|
3wrkA |
Crystal structure of p450cam |
|
151
|
405
|
3wrmA |
Crystal structure of p450cam |
|
145
|
451
|
3zg2A |
Sterol 14 alpha-demethylase (cyp51) from trypanosoma cruzi in complex with the pyridine inhibitor (s)-2-(4-chlorophenyl)-2-(pyridin-3-yl)-1- (4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone (epl-bs1246,udo) |
|
149
|
405
|
3wrjA |
Crystal structure of p450cam |
|
155
|
402
|
3zbyA |
Ligand-free structure of cyp142 from mycobacterium smegmatis |
|
131
|
401
|
3wecA |
Structure of p450 raua (cyp1050a1) complexed with a biosynthetic intermediate of aurachin re |
|
154
|
405
|
3wrhA |
Crystal structure of p450cam |
|
141
|
450
|
3zg3A |
Sterol 14-alpha demethylase (cyp51)from trypanosoma cruzi in complex with the pyridine inhibitor n-(1-(5-(trifluoromethyl)(pyridin-2-yl)) piperidin-4yl)-n-(4-(trifluoromethyl)phenyl)pyridin-3-amine (epl- bs967, udd) |
|
139
|
407
|
3vooA |
Cytochrome p450sp alpha (cyp152b1) mutant a245e |
|
136
|
407
|
3vnoA |
Cytochrome p450sp alpha (cyp152b1) mutant r241e |
|
143
|
407
|
3vm4A |
Cytochrome p450sp alpha (cyp152b1) in complex with (r)-ibuprophen |
|
135
|
402
|
3vrmA |
Structure of cytochrome p450 vdh mutant t107a with bound vitamin d3 |
|
135
|
407
|
3vtjA |
Cytochrome p450sp alpha (cyp152b1) mutant a245h |
|
164
|
482
|
3v8dA |
Crystal structure of human cyp7a1 in complex with 7-ketocholesterol |
|
158
|
465
|
3uasA |
Cytochrome p450 2b4 covalently bound to the mechanism-based inactivator 9-ethynylphenanthrene |
|
153
|
465
|
3ua5A |
Crystal structure of p450 2b6 (y226h/k262r) in complex with two molecules of amlodipine |
|
134
|
402
|
3tzoA |
The role of i87 of cyp158a2 in oxidative coupling reaction |
|
157
|
469
|
3ua1A |
Crystal structure of the cytochrome p4503a4-bromoergocryptine complex |
|
112
|
397
|
3tywA |
Crystal structure of cyp105n1 from streptomyces coelicolor a3(2) |
|
154
|
468
|
3tjsA |
Crystal structure of the complex between human cytochrome p450 3a4 and desthiazolylmethyloxycarbonyl ritonavir |
|
160
|
465
|
3tk3A |
Cytochrome p450 2b4 mutant l437a in complex with 4-(4-chlorophenyl)imidazole |
|
161
|
465
|
3tmzA |
Crystal structure of p450 2b4(h226y) in complex with amlodipine |
|
140
|
427
|
3tktA |
Crystal structure of cyp108d1 from novosphingobium aromaticivorans dsm12444 |
|
162
|
467
|
3tdaA |
Competitive replacement of thioridazine by prinomastat in crystals of cytochrome p450 2d6 |
|
163
|
467
|
3tbgA |
Human cytochrome p450 2d6 with two thioridazines bound in active site |
|
162
|
450
|
3tikA |
Sterol 14-alpha demethylase (cyp51) from trypanosoma brucei in complex with the tipifarnib derivative 6-((4-chlorophenyl)(methoxy)(1-methyl-1h-imidazol-5-yl)methyl)-4-(2,6-difluorophenyl)-1-methylquinolin-2(1h)-one |
|
154
|
464
|
3t3sA |
Human cytochrome p450 2a13 in complex with pilocarpine |
|
170
|
464
|
3t3zA |
Human cytochrome p450 2e1 in complex with pilocarpine |
